Literature DB >> 19428041

Vaccinia virus strain differences in cell attachment and entry.

Zain Bengali1, Alan C Townsley, Bernard Moss.   

Abstract

Vaccinia virus (VACV) strain WR can enter cells by a low pH endosomal pathway or direct fusion with the plasma membrane at neutral pH. Here, we compared attachment and entry of five VACV strains in six cell lines and discovered two major patterns. Only WR exhibited pH 5-enhanced rate of entry following neutral pH adsorption to cells, which correlated with sensitivity to bafilomycin A1, an inhibitor of endosomal acidification. Entry of IHD-J, Copenhagen and Elstree strains were neither accelerated by pH 5 treatment nor prevented by bafilomycin A1. Entry of the Wyeth strain, although not augmented by pH 5, was inhibited by bafilomycin A1. WR and Wyeth were both relatively resistant to the negative effects of heparin on entry, whereas the other strains were extremely sensitive due to inhibition of cell binding. The relative sensitivities of individual vaccinia virus strains to heparin correlated inversely with their abilities to bind to and enter glycosaminoglycan-deficient sog9 cells but not other cell lines tested. These results suggested that that IHD-J, Copenhagen and Elstree have a more limited ability than WR and Wyeth to use the low pH endosomal pathway and are more dependent on binding to glycosaminoglycans for cell attachment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428041      PMCID: PMC2700833          DOI: 10.1016/j.virol.2009.04.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.

Authors:  Erica Brown; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.

Authors:  Suany Ojeda; Arban Domi; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.

Authors:  Alan C Townsley; Andrea S Weisberg; Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Poxvirus multiprotein entry-fusion complex.

Authors:  Tatiana G Senkevich; Suany Ojeda; Alan Townsley; Gretchen E Nelson; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

5.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  The envelope G3L protein is essential for entry of vaccinia virus into host cells.

Authors:  Ruzan A Izmailyan; Cheng-Yen Huang; Shamim Mohammad; Stuart N Isaacs; Wen Chang
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

9.  Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin.

Authors:  Wen-Ling Chiu; Chi-Long Lin; Min-Hsiang Yang; Der-Lii M Tzou; Wen Chang
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

10.  Ligand-induced and nonfusogenic dissolution of a viral membrane.

Authors:  Mansun Law; Gemma C Carter; Kim L Roberts; Michael Hollinshead; Geoffrey L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

View more
  49 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Vaccinia virus A25 and A26 proteins are fusion suppressors for mature virions and determine strain-specific virus entry pathways into HeLa, CHO-K1, and L cells.

Authors:  Shu-Jung Chang; Yu-Xun Chang; Roza Izmailyan; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

3.  Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.

Authors:  Shu-Jung Chang; Ao-Chun Shih; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Oncolytic Poxviruses.

Authors:  Winnie M Chan; Grant McFadden
Journal:  Annu Rev Virol       Date:  2014-09-01       Impact factor: 10.431

5.  Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells.

Authors:  Nancy Y Villa; Eric Bartee; Mohamed R Mohamed; Masmudur M Rahman; John W Barrett; Grant McFadden
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

6.  Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.

Authors:  Cindy L Wolfe; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 7.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

8.  Intracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH-VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22.

Authors:  Jye-Chian Hsiao; Li-Wei Chu; Yung-Tsun Lo; Sue-Ping Lee; Tzu-Jung Chen; Cheng-Yen Huang; Yueh-Hsin Ping; Wen Chang
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

9.  Myxoma and vaccinia viruses bind differentially to human leukocytes.

Authors:  Winnie M Chan; Eric C Bartee; Jan S Moreb; Ken Dower; John H Connor; Grant McFadden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics.

Authors:  Theresa S Moser; Russell G Jones; Craig B Thompson; Carolyn B Coyne; Sara Cherry
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.